These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 16004887)

  • 21. Low-dose paclitaxel elution by novel bioerodible sol-gel coating on stents inhibits neointima with low toxicity in porcine coronary arteries.
    Shinke T; Geva S; Pendyala L; Jabara R; Li J; Chen JP; Venegoni A; Colley K; Klein R; Chronos N; Robinson K; Hou D
    Int J Cardiol; 2009 Jun; 135(1):93-101. PubMed ID: 18692915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zotarolimus-eluting stents reduce experimental coronary artery neointimal hyperplasia after 4 weeks.
    Garcia-Touchard A; Burke SE; Toner JL; Cromack K; Schwartz RS
    Eur Heart J; 2006 Apr; 27(8):988-93. PubMed ID: 16449248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of stem cell mobilization by granulocyte-colony stimulating factor on neointimal hyperplasia and endothelial healing after vascular injury with bare-metal versus paclitaxel-eluting stents.
    Cho HJ; Kim TY; Cho HJ; Park KW; Zhang SY; Kim JH; Kim SH; Hahn JY; Kang HJ; Park YB; Kim HS
    J Am Coll Cardiol; 2006 Jul; 48(2):366-74. PubMed ID: 16843188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biocompatibility of tetramethylpyrazine-eluting stents in normal porcine coronary arteries.
    Ma GS; Chen LJ; Chen Z; Ding S; Shen CX; Feng Y
    Biomed Pharmacother; 2008 Feb; 62(2):125-9. PubMed ID: 17764890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Local paclitaxel delivery after coronary stenting in an experimental animal model.
    Dommke C; Haase KK; Süselbeck T; Streitner I; Haghi D; Metz J; Borggrefe M; Herdeg C
    Thromb Haemost; 2007 Sep; 98(3):674-80. PubMed ID: 17849059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative healing response after sirolimus- and paclitaxel-eluting stent implantation in a pig model of restenosis.
    Silva GV; Fernandes MR; Madonna R; Clubb F; Oliveira E; Jimenez-Quevedo P; Branco R; Lopez J; Angeli FS; Sanz-Ruiz R; Vaughn WK; Zheng Y; Baimbridge F; Canales J; Cardoso CO; Assad JA; Falotico R; Perin EC
    Catheter Cardiovasc Interv; 2009 May; 73(6):801-8. PubMed ID: 19309735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of combined treatment with angiotensin II type 1 receptor blocker and statin on stent restenosis.
    Yoshikawa M; Nakamura K; Nagase S; Sakuragi S; Kusano KF; Matsubara H; Ohe T
    J Cardiovasc Pharmacol; 2009 Feb; 53(2):179-86. PubMed ID: 19188828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two-year follow-up of the quantitative angiographic and volumetric intravascular ultrasound analysis after nonpolymeric paclitaxel-eluting stent implantation: late "catch-up" phenomenon from ASPECT Study.
    Park DW; Hong MK; Mintz GS; Lee CW; Song JM; Han KH; Kang DH; Cheong SS; Song JK; Kim JJ; Weissman NJ; Park SW; Park SJ
    J Am Coll Cardiol; 2006 Dec; 48(12):2432-9. PubMed ID: 17174179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of 36 reported cases of late thrombosis in drug-eluting stents placed in coronary arteries.
    Artang R; Dieter RS
    Am J Cardiol; 2007 Apr; 99(8):1039-43. PubMed ID: 17437724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjustable paclitaxel release kinetics and its efficacy to inhibit smooth muscle cells proliferation.
    Lao LL; Venkatraman SS
    J Control Release; 2008 Aug; 130(1):9-14. PubMed ID: 18599145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlled delivery of paclitaxel from stent coatings using novel styrene maleic anhydride copolymer formulations.
    Richard R; Schwarz M; Chan K; Teigen N; Boden M
    J Biomed Mater Res A; 2009 Aug; 90(2):522-32. PubMed ID: 18563805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are impaired endothelial progenitor cells involved in the processes of late in-stent thrombosis and re-endothelialization of drug-eluting stents?
    Zhao FH; Chen YD; Jin ZN; Lu SZ
    Med Hypotheses; 2008; 70(3):512-4. PubMed ID: 17764856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical evidence on polymer-based sirolimus and paclitaxel eluting stents.
    Iijima R; Mehilli J; Schömig A; Kastrati A
    Minerva Cardioangiol; 2006 Oct; 54(5):539-55. PubMed ID: 17019392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local vascular toxicokinetics of stent-based drug delivery.
    Tesfamariam B
    Toxicol Lett; 2007 Jan; 168(2):93-102. PubMed ID: 17169513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-eluting stent update 2007: part II: Unsettled issues.
    Daemen J; Serruys PW
    Circulation; 2007 Aug; 116(8):961-8. PubMed ID: 17709651
    [No Abstract]   [Full Text] [Related]  

  • 37. Effectiveness and safety of the sirolimus-eluting stents coated with bioabsorbable polymer coating in human coronary arteries.
    Ge J; Qian J; Wang X; Wang Q; Yan W; Yan Y; Fan B; Ge L; Liu X
    Catheter Cardiovasc Interv; 2007 Feb; 69(2):198-202. PubMed ID: 17195205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vessel size and outcome after coronary drug-eluting stent placement: results from a large cohort of patients treated with sirolimus- or paclitaxel-eluting stents.
    Elezi S; Dibra A; Mehilli J; Pache J; Wessely R; Schömig A; Kastrati A
    J Am Coll Cardiol; 2006 Oct; 48(7):1304-9. PubMed ID: 17010786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of abciximab on key pattern of human coronary restenosis in vitro: impact of the SI/MPL-ratio.
    Voisard R; Alan M; von Müller L; Baur R; Hombach V
    BMC Cardiovasc Disord; 2006 Apr; 6():14. PubMed ID: 16595000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Optimal platelet inhibition after coronary stent implantation. Current status].
    Silber S; Hoffmeister HM; Bode C
    Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.